Olema Pharmaceuticals, Inc. (OLMA) ownership: Entities affiliated with FMR LLC (1) 25% · institutions 134% · index and ETF funds 6% (13F 2026-06-30). Insider activity, 90 days: 2 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| FMR (Fidelity) | 12143062.00 | $151.91M | 13.9% | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 8670576.00 | $108.47M | 9.9% | 2026-06-30 |
| Janus Henderson | 7108488.00 | $106.01M | 8.1% | 2026-06-30 |
| Jupiter Topco LLC | 7094413.00 | $88.80M | 8.1% | 2026-06-30 |
| Bain Capital Life Sciences Investors, LLC | 7085249.00 | $88.64M | 8.1% | 2026-06-30 |
| BlackRock | 6714691.00 | $84.00M | 7.7% | 2026-06-30 |
| Vanguard | 5487162.00 | $68.64M | 6.3% | 2026-06-30 |
| BVF Inc/il | 5295893.00 | $66.25M | 6.1% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-09-01 | |
| Sell | null | 2026-07-23 | |
| Sell | null | 2026-07-23 | |
| Sell | null | 2026-06-18 | |
| Sell | null | 2026-06-18 | |
| Sell | null | 2026-06-18 | |
| Sell | null | 2026-06-18 | |
| Sell | null | 2026-06-18 |
Back to OLMA overview · OLMA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.